SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences informs about outcome of board meeting

05 Aug 2020 Evaluate

Eris Lifesciences has informed that the Board of Directors of the company at their meeting held on August 4, 2020 has transacted the following business: to convene the Annual General Meeting (AGM) of the Members of the Company on Tuesday, September 29, 2020. Appointment of Kaushal Kamlesh Shah (DIN: 01229038) as an additional Director of the Company, with effective from August 04, 2020 until the ensuing Annual General Meeting of the members of the Company to be held in calendar year 2020. The brief profile of Kaushal Kamlesh Shah is enclosed.

The above information is a part of company’s filings submitted to BSE.


Eris Lifesciences Share Price

1446.50 -18.90 (-1.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×